FDA Suspects Fraud Led To Heparin Contamination

Law360, New York (April 16, 2008, 12:00 AM EDT) -- The U.S. Food and Drug Administration told a Senate hearing on Tuesday that Baxter International Inc.'s heparin, a blood thinner that has been linked to several deaths and allergic reactions, may have been contaminated purposefully in an attempt to lower the cost of the product.

The main ingredient in some samples of Baxter's heparin had been contaminated by a cheaper substance with similar qualities that was derived from animal cartilage, FDA Commissioner Dr. Andrew von Eschenbach said.

Though the agency is not completely sure that the...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.